Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-03-19Clinical Trial Update: THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) [Phase 3]
A Phase 3 trial evaluating thromboprophylaxis in sickle cell disease patients with central venous catheters has been terminated.
-
CLINICAL_TRIALS withdrawal · 2024-11-13Clinical Trial Update: Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm
The trial evaluating the XAPPORT decision-support app for managing anticoagulation in patients treated with rivaroxaban undergoing elective …
-
CLINICAL_TRIALS withdrawal · 2024-09-03Clinical Trial Update: Detecting Circulating Emboli in Patients with Acute Venous Thromboembolism [NA]
A clinical trial investigating detection of circulating emboli in patients with acute venous thromboembolism has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-26Clinical Trial Update: A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot
A Boehringer Ingelheim-sponsored European study assessing the safety of dabigatran in children under 2 with prior venous thromboembolism has…
-
CLINICAL_TRIALS withdrawal · 2024-04-18Clinical Trial Update: SAVES-IBD: Safety & Efficacy of Aspirin vs. Standard of Care for VTE Prophylaxis After IBD Surgery [Phase 3]
A Phase 3 trial assessing aspirin versus standard of care for VTE prophylaxis after IBD surgery has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2021-10-08Clinical Trial Update: Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study [Phase 4]
A Phase 4 randomized trial evaluating enoxaparin versus placebo for preventing venous thromboembolism in low-risk cancer patients after surg…
-
EMA withdrawal · 2019-10-24EMA Lapsed: Thorinane (enoxaparin sodium) — Pharmathen S.A.
EMA has lapsed the marketing authorisation for Thorinane (enoxaparin sodium) by Pharmathen S.A., with the therapeutic area being venous thro…
-
CLINICAL_TRIALS withdrawal · 2019-08-16Clinical Trial Update: Timing of VTE Prophylaxis in TBI [Phase 4]
A Phase 4 trial evaluating timing of VTE prophylaxis in traumatic brain injury has been withdrawn.
-
EMA withdrawal · 2018-10-09EMA Refused: Dexxience (betrixaban maleate) — Portola Pharma UK Limited
EMA refused Dexxience (betrixaban) application for venous thromboembolism therapy.
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients [NA]
A clinical trial evaluating intravenous continuous infusion heparin to reduce venous thromboembolism in high-risk, critically ill patients w…
-
CLINICAL_TRIALS withdrawal · 2017-03-23Clinical Trial Update: Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
The FLUTE trial evaluating fetal loss in women with unprovoked venous thromboembolism was terminated; no trial results are provided in this …
-
CLINICAL_TRIALS withdrawal · 2017-01-31Clinical Trial Update: Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy [NA]
A clinical trial evaluating a novel dabigatran-based peri-operative bridging protocol for patients on chronic warfarin therapy has been with…
-
CLINICAL_TRIALS withdrawal · 2016-06-22Clinical Trial Update: Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients
A multicenter registry study evaluating comparative effectiveness of venous thromboembolism management in trauma patients has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2016-04-22Clinical Trial Update: Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System
This study evaluating the Crux Vena Cava Filter System was withdrawn; no study results have been reported.
-
CLINICAL_TRIALS withdrawal · 2016-02-04Clinical Trial Update: Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)
The Bayer-sponsored trial evaluating rivaroxaban for venous thromboembolism prophylaxis after elective total knee replacement or total hip r…
-
CLINICAL_TRIALS withdrawal · 2015-10-26Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age [Phase 2]
A Phase 2 pediatric trial evaluating the pharmacokinetics, safety and tolerability of dabigatran etexilate solution in children aged 1 to le…
-
CLINICAL_TRIALS withdrawal · 2015-08-10Clinical Trial Update: Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection [NA]
This ClinicalTrials.gov update indicates the study evaluating predictive whole-blood coagulation parameters for post-discharge venous thromb…
-
CLINICAL_TRIALS withdrawal · 2013-08-27Clinical Trial Update: Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery [Phase 3]
A Phase 3 trial evaluating enoxaparin in children with asymptomatic venous thrombosis after pediatric cardiac surgery has been withdrawn. Th…
-
CLINICAL_TRIALS withdrawal · 2013-04-04Clinical Trial Update: Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR) [Phase 2]
This clinical trial update reports that the Phase IIa Venous Thromboembolism (VTE) prevention study in total knee replacement was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-03-29Clinical Trial Update: Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients [Phase 3]
A Phase 3 trial evaluating sodium heparin for prophylaxis of venous thromboembolism in surgical patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-04-19Clinical Trial Update: Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
A clinical trial update reporting a systematic review and meta-analysis of venous thromboembolism risk assessment in hospitalized medical pa…
-
CLINICAL_TRIALS withdrawal · 2010-12-10Clinical Trial Update: Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis [Phase 3]
A Phase 3 trial investigating rosuvastatin for prevention of thrombosis in patients with prior venous thrombosis and pulmonary embolism has …